期刊文献+

老年人关节置换术后静脉血栓栓塞症的防治 被引量:11

Prevention and treatment of venous thromboembolism in elderly patients after joint replacement
原文传递
导出
摘要 目的 探讨老年人关节置换术后血栓前状态和血液中凝血-纤溶系统指标变化与深静脉血栓形成(DVT)发生的相关性. 方法 观察我院2003年1月至2011年6月行髋、膝关节置换术的老年患者400例,根据威尔氏首诊临床(Well' s)评分分为疑似DVT组和非疑似DVT组各200例,再根据患者病情且在其知情同意的情况下分别分为4组:(1)低分子肝素组;(2)间断气囊压迫组;(3)联合治疗组(低分子肝素加间断气囊压迫);(4)空白对照组:均为拒绝应用预防治疗的患者.术前检测凝血酶-抗凝血酶复合物(TAT)、纤溶酶-α2抗纤溶酶复合物(PAP);术前和术后第4、10天行双下肢血管超声检查. 结果 各组患者术后DVT共发生71例(17.8%),肺血栓栓塞症5例(1.3%).疑似DVT组患者术后DVT发生率为28.5%(57例),与非疑似DVT组7.0%(14例)比较,差异有统计学意义(x2=31.66,P<0.01).疑似DVT组中,联合治疗组DVT发生率与低分子肝素组、间断气囊压迫组及对照组比较差异均有统计学意义(x2值分别为4.89、17.34、18.01,均P<0.05).非疑似DVT组中,联合治疗组DVT发生率与对照组比较差异有统计学意义(x2=13.64,P<0.01).术后并发DVT患者术前平均TAT水平为(9.63±3.06)μg/L,高于无DVT患者(2.59±0.87)μg/L,术前平均PAP水平(38.52±21.13)μg/L,低于无DVT患者(69.75±30.26)μg/L,差异均有统计学意义(t值分别为35.70、8.27,均P<0.01). 结论 术前TAT和PAP水平检测对髋、膝关节置换术患者术后发生DVT具有一定的预测价值.应用Well's评分对DVT不同危险程度老年人采用不同的预防措施,可提高预防效果. Objective To explore the relationship between the prothrombotic state and blood coagulation-fibrinolysis system changes with deep venous thrombosis(DVT)in aged patients after total joint arthroplasty,and to propose preventive measures.Methods 400 patients who underwent total hip or knee replacement from January 2003 to June 2011 were classified into suspected DVT(n=200 cases)and non-suspected DVT(n=200 cases)according to Well's clinical scoring system.The patients were divided into 4 subgroups based on the measures to prevent DVT:low molecular weigh heparin group,intermittent pneumatic bag compression group,combined above measures group,control group who refused any preventive measures.Plasma thrombin-antithrombin complex(TAT),plasmin-α2 antiplasmin complex(PAP)were determined preoperatively.Venous Doppler ultrasound was performed before surgery,4 d and 10 d after surgery to detect the presence of DVT.Results Totally 71 cases(17.8%)were diagnosed as DVT and 5 cases(1.3%)as pulmonary thromboembolism(PTE).The incidence of DVT in suspected DVT group(28.5%,57 cases)was lower than in non-suspected DVT group(7.0 %,14 cases)(x2 =31.66,P〈 0.01).Among patients with suspected DVT,the DVT prevalence in combined measures group(2.0 %,1 cases)was decreased than in low molecular weigh heparin group(14.0%,7 cases),intermittent pneumatic bag compression (34.0%,17 cases)and control groups(64.0%,32 cases)(x2=4.89,17.34,18.01,all P〈0.05).In the patients with non-suspected DVT,the DVT prevalence in combined measures group(0.0%)was lower than in control group(24.0 %,12 cases)(x2 =13.64,P〈0.01).The average preoperative level of TAT[(9.63±3.06)μg/L]in patients with DVT was higher than without DVT[(2.59±0.87)μg/L](t=35.70,P〈0.01),while PAP level in patients with DVT[(38.52± 21.13)μg/L]was reduced than without DVT[69.75±30.26)μg/L](t=8.27,P〈0.01).Conclusions The levels of TAT and PAP before total hip or knee replacement are predictive for lower extremity DVT.The clinical effectiveness of Well's scoring on DVT prevention is dependent on the different TAT and PAP state.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第2期136-139,共4页 Chinese Journal of Geriatrics
基金 国家“十五”科技攻关课题资助(2001BA703815) 烟台市科技发展计划资助(2002114)
关键词 关节成形术 置换 静脉血栓形成 肺栓塞 Arthroplasty,replacement Venous thrombosis Pulmonary embolism
  • 相关文献

参考文献10

  • 1Sanchez O,Planquette B,Meyer G.Update on acute pulmonary embolism.Eur Respir Rev,2009,18:137-147.
  • 2Kearon C,Kahn SR,Agnell G,et al.Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians EvidenceBased Clinical Practice Guidelines(8th Edition).Chest,2008,133:454-545.
  • 3Torbicki A,Perrier A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmonary embolism:the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).Eur Heart J,2008,29:2276-2315.
  • 4Toker S,Hak DJ,Morgan SJ.Deep vein thrombosis prophylaxis in trauma patients.Thrombosis,2011,2011:505373.
  • 5Parvizi J,Azzam K,Rothman RH.Deep venous thrombosis prophylaxis for total joint arthroplasty:American Academy of Orthopaedic Surgeons guidelines.J Arthroplasty,2008,23:2-5.
  • 6Pellegrini VD Jr,Sharrock NE,Paiement GD,et al.Venous thromboembolic disease after total hip and knee arthroplasty:current perspectives in a regulated environment.Instr Course Lect,2008,57:637-661.
  • 7Dorr LD,Gendelman V,Maheshwari AV,et al.Multimodal thromboprophyl-axis for total hip and knee arthroplasty based on risk assessment.J Bone Joint Surg Am,2007,89:2648-2657.
  • 8杨扬,董梅,齐宝庆.老年人下肢骨折的围手术期治疗[J].中华老年医学杂志,2011,30(2):160-161. 被引量:2
  • 9Lassen MR,Gallus A,Raskob GE,et al.Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.N EnglJ Med,2010,363:2487-2498.
  • 10Lippi G,Cervellin G,Franchini M,et al.Biochemical markers for the diagnosis of venous thromboembolism:the past,present and future.J Thromb Thrombolysis,2010,30:459-471.

二级参考文献4

共引文献1

同被引文献99

引证文献11

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部